Tello-Montoliu A, Patel J V, Lip G Y H
Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK.
J Thromb Haemost. 2006 Sep;4(9):1864-74. doi: 10.1111/j.1538-7836.2006.01995.x.
Angiogenin is a member of the ribonuclease (RNase) superfamily: enzymes of innate substrate specificity, but divergent functional capacities. Angiogenin is a normal constituent of the circulation and contained in a vasculature that rarely undergoes proliferation, but in some physiological and pathological conditions its levels increase in blood, promoting neovascularization. Hence, angiogenesis is a common pathophysiological attribute of angiogenin. In malignant disease, the most studied pathological state in regard to angionenin, abnormally high levels are seen, which may be of prognostic significance. Angiogenin has also been studied in other non-malignant pathological states. The aim of this review article is to provide an overview of the biochemistry and physiology of angiogenin, specifically in relation to the human pathological states where angiogenin has been implicated and finally, its potential clinical applications.
血管生成素是核糖核酸酶(RNase)超家族的成员之一:这类酶具有固有的底物特异性,但功能能力却有所不同。血管生成素是循环系统的正常组成成分,存在于很少发生增殖的脉管系统中,但在某些生理和病理条件下,其在血液中的水平会升高,从而促进新血管形成。因此,血管生成是血管生成素常见的病理生理特性。在恶性疾病(血管生成素研究最多的病理状态)中,会出现异常高水平的血管生成素,这可能具有预后意义。血管生成素也在其他非恶性病理状态中得到了研究。这篇综述文章的目的是概述血管生成素的生物化学和生理学,特别是与血管生成素相关的人类病理状态,以及其潜在的临床应用。